Landmark trial
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Pötter R, Tanderup K, Schmid MP, et al. · EMBRACE Collaborative Group
DoseLab summary
EMBRACE-I, a prospective multicenter cohort of chemoradiation with MRI-guided adaptive brachytherapy for locally advanced cervical cancer, reporting high local control and the dose–response relationships behind the EMBRACE II planning aims. Citation checked against Europe PMC.
Why this is useful
The outcome data behind image-guided adaptive brachytherapy.
Reference details
- Title
- MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
- Authors / organization
- Pötter R, Tanderup K, Schmid MP, et al. · EMBRACE Collaborative Group
- Publication / protocol
- Lancet Oncol. 2021;22(4):538–547
- Version
- Pending verification
- Year
- 2021
- DOI
- 10.1016/S1470-2045(20)30753-1
- Disease sites
- GYN
- Topics
- Cervix, Brachytherapy, IGABT
- Fractionation context
- Pending verification
- Last reviewed by DoseLab
- Pending verification